Skip to main content

Table 1 Intensity of systemic and local reactions

From: An accelerated dose escalation with a grass pollen allergoid is safe and well-tolerated: a randomized open label phase II trial

  Intensitya Group I accelerated (N = 61) Group II conventional (N = 61)
Systemic reaction Mild 8 (13.1 %) 2 (3.3 %)
Moderate 0 (0.0 %) 2 (3.3 %)
Severe 0 (0.0 %) 0 (0.0 %)
Injection site swelling Mild 10 (16.4 %) 5 (8.2 %)
Moderate 2 (3.3 %) 1 (1.6 %)
Severe 1 (1.6 %) 0 (0.0 %)
Injection site erythema Mild 10 (16.4 %) 7 (11.5 %)
Moderate 1 (1.6 %) 0 (0.0 %)
Severe 0 (0.0 %) 0 (0.0 %)
  1. aEach patient counted once under the highest intensity